Carl H. June, MD

Affiliations: 
Pathology University of Pennsylvania, Philadelphia, PA, United States 
Google:
"Carl June"

Children

Sign in to add trainee
Luk H. Vandenberghe grad student Penn
Marcela V. Maus grad student 2003 Penn
Megan M. Suhoski grad student 2008 Penn

Collaborators

Sign in to add collaborator
Sadik H Kassim collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Garfall AL, Stadtmauer EA, Hwang WT, et al. (2019) Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. Jci Insight. 4
Boyiadzis MM, Dhodapkar MV, Brentjens RJ, et al. (2018) Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance. Journal For Immunotherapy of Cancer. 6: 137
Choi BD, Maus MV, June CH, et al. (2018) ----Immunotherapy for Glioblastoma: Adoptive T-cell Strategies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Kloss CC, Lee J, Zhang A, et al. (2018) Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication. Molecular Therapy : the Journal of the American Society of Gene Therapy
Garfall AL, Stadtmauer EA, Hwang WT, et al. (2018) Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. Jci Insight. 3
O'Rourke DM, Nasrallah MP, Desai A, et al. (2017) A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Science Translational Medicine. 9
Long M, Beckwith K, Do P, et al. (2017) Ibrutinib treatment improves T cell number and function in CLL patients. The Journal of Clinical Investigation
Sampson JH, Maus MV, June CH. (2017) Immunotherapy for Brain Tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017728089
Tanyi JL, Stashwick C, Plesa G, et al. (2017) Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells. Journal of Immunotherapy (Hagerstown, Md. : 1997)
Posey AD, Schwab RD, Boesteanu AC, et al. (2016) Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma. Immunity. 44: 1444-1454
See more...